InsiderTrades

Form 4 for GEVO Gevo, Inc.

Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0002071241-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-08 2025-12-05 GEVO Agiri Oluwagbemileke Yusuf CFO S - Sale+OE $2.31 -73.3K 271.2K -21% -$169.3K
DM 2025-12-08 2025-12-05 GEVO Agiri Oluwagbemileke Yusuf CFO M - OptEx $1.18 +68.4K 312.6K +28% +$80.6K
DM 2025-12-08 2025-12-05 GEVO Agiri Oluwagbemileke Yusuf CFO M - OptEx $0.00 +68.4K 18.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-05 S D 73,284 $2.31 271,224 D — — (F1) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.29 to $2.335 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2 Common Common Stock 2025-12-05 M A 31,958 $0.71 344,508 D — —
3 Common Common Stock 2025-12-05 M A 36,446 $1.59 312,550 D — —
4 Derivative Stock Option 2025-12-05 M A 31,958 $0.00 63,917 D $0.71 · — to 2034-05-21 31,958 Common Stock (F4) The option became exercisable in three equal annual installments beginning on May 22, 2025.
5 Derivative Stock Option 2025-12-05 M A 36,446 $0.00 18,223 D $1.59 · — to 2033-08-03 36,446 Common Stock (F3) The option became exercisable in three equal annual installments beginning on August 3, 2024.